Skip to content

FRATES JAMES M

Reporting owner on Forms 3, 4 and 5, CIK 1235598.

FRATES JAMES M reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-12.

Issuers

IssuerRoles in the latest filingFilingsLast filed
AMLX · Amylyx Pharmaceuticals, Inc.CIK 1658551officer (Chief Financial Officer)12026-11-12

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-10M exercised+20,000$6.88253,625Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-10S sold-12,800$30.3209240,825Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-10S sold-7,200$30.9698233,625Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Stock Option (right to buy), derivative2026-11-10M exercised-20,000$0323,835Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-09M exercised+20,000$6.88253,625Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-09S sold-7,700$29.3887245,925Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock2026-11-09S sold-12,300$30.1105233,625Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock, holding 100,000Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock, holding 15,459Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock, holding 11,072Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Common Stock, holding 40,000Form 4
AMLX · Amylyx Pharmaceuticals, Inc.Stock Option (right to buy), derivative2026-11-09M exercised-20,000$0343,835Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001193125-26-458247 Amylyx Pharmaceuticals, Inc.2026-11-12